National advertising division refers maze therapeutics to regulatory authorities for failure to respond to inquiry

Following a challenge brought by vertex pharmaceuticals incorporated, bbb national programs' national advertising division will refer claims made by maze therapeutics, inc. to the appropriate regulatory authorities for review and possible enforcement action for failure to submit a substantive response to the national advertising division's (nad) inquiry. following a challenge brought by vertex pharmaceuticals incorporated, bbb national programs' national advertising division will refer claims made by maze therapeutics, inc. to the appropriate regulatory authorities for review and possible enforcement action for failure to submit a substantive response to the national advertising division's (nad) inquiry.
VRTX Ratings Summary
VRTX Quant Ranking